These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 32520686
1. Fetal Cardiac Cellular Damage Caused by Anemia in Utero in Hb Bart's Disease. Jatavan P, Kumfu S, Tongsong T, Chattipakorn N. Curr Mol Med; 2021; 21(2):165-175. PubMed ID: 32520686 [Abstract] [Full Text] [Related]
2. Fetal hemodynamic changes and mitochondrial dysfunction in myocardium and brain tissues in response to anemia: a lesson from hemoglobin Bart's disease. Luewan S, Apaijai N, Chattipakorn N, Chattipakorn SC, Tongsong T. BMC Pregnancy Childbirth; 2024 Feb 16; 24(1):141. PubMed ID: 38365664 [Abstract] [Full Text] [Related]
3. Fetal anemia causes placental and maternal cellular damage: a lesson from fetal hemoglobin Bart's disease. Luewan S, Apaijai N, Chattipakorn N, Chattipakorn S, Tongsong T. Placenta; 2024 Apr 16; 149():72-77. PubMed ID: 38531214 [Abstract] [Full Text] [Related]
4. Fetal septum primum excursion (SPE) and septum primum excursion index (SPEI) as sonomarkers of fetal anemia: using hemoglobin Bart's fetuses as a study model. Sirilert S, Tongprasert F, Srisupundit K, Luewan S, Tongsong T. Prenat Diagn; 2016 Jul 16; 36(7):680-5. PubMed ID: 27174768 [Abstract] [Full Text] [Related]
5. Fetal hemoglobin Bart's hydrops fetalis: pathophysiology, prenatal diagnosis and possibility of intrauterine treatment. Jatavan P, Chattipakorn N, Tongsong T. J Matern Fetal Neonatal Med; 2018 Apr 16; 31(7):946-957. PubMed ID: 28277912 [Abstract] [Full Text] [Related]
6. Ventricular Diastolic Function in Normal Fetuses and Fetuses with Hb Bart's Disease Assessed by Color M-Mode Propagation Velocity using Cardio-STIC-M (Spatio-Temporal Image Correlation M-Mode). Tongsong T, Tongprasert F, Srisupundit K, Luewan S, Traisrisilp K. Ultraschall Med; 2016 Oct 16; 37(5):492-496. PubMed ID: 26529356 [Abstract] [Full Text] [Related]
7. Comparison of cardiac troponin T and N-terminal pro-B-type natriuretic peptide between fetuses with hemoglobin Bart's disease and nonanemic fetuses. Tongprasert F, Srisupundit K, Luewan S, Tongsong T. Prenat Diagn; 2014 Sep 16; 34(9):864-9. PubMed ID: 24733401 [Abstract] [Full Text] [Related]
8. Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio. Thathan N, Traisrisilp K, Luewan S, Srisupundit K, Tongprasert F, Tongsong T. BMC Pregnancy Childbirth; 2014 Jul 16; 14():230. PubMed ID: 25028081 [Abstract] [Full Text] [Related]
9. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy. Srisupundit K, Piyamongkol W, Tongsong T. Am J Hematol; 2008 Dec 16; 83(12):908-10. PubMed ID: 18932192 [Abstract] [Full Text] [Related]
10. Diagnostic value of fetal hemoglobin Bart's for evaluation of fetal α-thalassemia syndromes: application to prenatal characterization of fetal anemia caused by undiagnosed α-hemoglobinopathy. Singha K, Yamsri S, Chaibunruang A, Srivorakun H, Sanchaisuriya K, Fucharoen G, Fucharoen S. Orphanet J Rare Dis; 2022 Feb 10; 17(1):45. PubMed ID: 35144630 [Abstract] [Full Text] [Related]